SNORD114-21: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD114-21

NCBI ID: G767599

SNORD114-21

Other Name(s): Small nucleolar RNA, C/D box 114-21 | 14q(II-21) | small nucleolar RNA, C/D box 114-21

SNORD114-21: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the key functions of snRNA is to help maintain the stability of chromatin by base pairing with specific mRNAs and preventing their degradation. C/D box 114-21 is a specific snRNA molecule that is expressed in various tissues and has been shown to play important roles in various cellular processes.

Recent studies have identified SNORD114-21 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. In this article, we will discuss the potential mechanisms by which SNORD114-21 can be targeted and how it can be used as a biomarker for disease diagnosis and treatment.

SNORD114-21 as a Drug Target

SNORD114-21 has been shown to play important roles in various cellular processes, including DNA replication, gene expression, and cellular signaling. It is a key regulator of the chromatin structure and has been shown to interact with various nuclear proteins, including histone modifiers and transcriptional factors.

One of the key functions of SNORD114-21 is its role in maintaining the stability of chromatin. Chromatin is a complex protein-nucleic acid complex that is highly resistant to various forms of damage, including UV radiation, temperature, and stress. SNORD114-21 has been shown to help maintain the stability of chromatin by base pairing with specific mRNAs and preventing their degradation.

SNORD114-21 is also involved in the regulation of gene expression. It has been shown to interact with various nuclear proteins, including histone modifiers and transcriptional factors, and to play important roles in regulating the expression of various genes. For example, studies have shown that SNORD114-21 can interact with the histone protein histone H3 and can help to maintain the stability of chromatin in the presence of histone modifications.

SNORD114-21 has also been shown to play important roles in cellular signaling. It has been shown to interact with various signaling pathways, including the PI3K/Akt signaling pathway, and to play important roles in regulating the expression of various genes that are involved in cellular signaling.

SNORD114-21 as a Biomarker

SNORD114-21 has been shown to play important roles in various cellular processes and has been identified as a potential biomarker for several diseases. One of the key advantages of SNORD114-21 as a biomarker is its stability and long half-life, which allows for its use as a biomarker for long periods of time.

Studies have shown that SNORD114-21 is expressed in various tissues and is involved in various cellular processes, including DNA replication, gene expression, and cellular signaling. It has been shown to play important roles in the regulation of gene expression and has been shown to interact with various nuclear proteins.

One of the key potential applications of SNORD114-21 as a biomarker is its use in disease diagnosis. Studies have shown that SNORD114-21 is expressed in various tissues and has been associated with various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

For example, studies have shown that SNORD114-21 is expressed in various tissues and is associated with cancer. This suggests that SNORD114-21 may be a useful biomarker for cancer diagnosis and treatment.

Another potential application of SNORD114-21 as a biomarker is its use in neurodegenerative diseases. Studies have shown that SNORD114-21 is expressed in various tissues

Protein Name: Small Nucleolar RNA, C/D Box 114-21

The "SNORD114-21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD114-21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets